133 related articles for article (PubMed ID: 38220587)
41. Unprovoked Venous Thromboembolism: The Search for the Cause.
Mwansa H; Zghouzi M; Barnes GD
Med Clin North Am; 2023 Sep; 107(5):861-882. PubMed ID: 37541713
[TBL] [Abstract][Full Text] [Related]
42. Sex Differences in Clinical Characteristics and Outcomes of Patients With Venous Thromboembolism - From the COMMAND VTE Registry.
Yoshikawa Y; Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Kimura T;
Circ J; 2019 Jun; 83(7):1581-1589. PubMed ID: 31142685
[TBL] [Abstract][Full Text] [Related]
43. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
Coleman CI; Bunz TJ; Turpie AGG
Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
[TBL] [Abstract][Full Text] [Related]
44. Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.
Amaral FC; Baptista-Silva JC; Nakano LC; Flumignan RL
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013683. PubMed ID: 36413425
[TBL] [Abstract][Full Text] [Related]
45. Safety of the pulmonary embolism rule-out criteria rule: Findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) registry.
Truong P; Mazzolai L; Font C; Ciammaichella M; González-Martínez J; Tufano A; Gavín-Sebastián O; Le Mao R; Monreal M; Hugli O;
Acad Emerg Med; 2023 Sep; 30(9):935-945. PubMed ID: 37092646
[TBL] [Abstract][Full Text] [Related]
46. Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: data from the RIETE registry.
Bertoletti L; Quenet S; Laporte S; Sahuquillo JC; Conget F; Pedrajas JM; Martin M; Casado I; Riera-Mestre A; Monreal M;
Respir Res; 2013 Jul; 14(1):75. PubMed ID: 23865769
[TBL] [Abstract][Full Text] [Related]
47. Clinical Characteristics and Outcomes of Women Presenting with Venous Thromboembolism during Pregnancy and Postpartum Period: Findings from the RIETE Registry.
Elgendy IY; Fogerty A; Blanco-Molina Á; Rosa V; Schellong S; Skride A; Portillo J; Lopez-Miguel P; Monreal M; Weinberg I
Thromb Haemost; 2020 Oct; 120(10):1454-1462. PubMed ID: 32717760
[TBL] [Abstract][Full Text] [Related]
48. Enoxaparin for Long-Term Therapy of Venous Thromboembolism in Patients with Cancer and Renal Insufficiency.
Sigüenza P; López-Núñez JJ; Falgá C; Gómez-Cuervo C; Riera-Mestre A; Gil-Díaz A; Verhamme P; Montenegro AC; Barbagelata C; Imbalzano E; Monreal M;
Thromb Haemost; 2024 Apr; 124(4):363-373. PubMed ID: 37832588
[TBL] [Abstract][Full Text] [Related]
49. Venous thromboembolism in very elderly patients: findings from a prospective registry (RIETE).
López-Jiménez L; Montero M; González-Fajardo JA; Arcelus JI; Suárez C; Lobo JL; Monreal M;
Haematologica; 2006 Aug; 91(8):1046-51. PubMed ID: 16885044
[TBL] [Abstract][Full Text] [Related]
50. Prognosis in patients with cancer-associated venous thromboembolism: Comparison of the RIETE-VTE and modified Ottawa score.
Pfaundler N; Limacher A; Stalder O; Méan M; Rodondi N; Baumgartner C; Aujesky D
J Thromb Haemost; 2020 May; 18(5):1154-1161. PubMed ID: 32124545
[TBL] [Abstract][Full Text] [Related]
51. Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
Brekelmans MP; Ageno W; Beenen LF; Brenner B; Buller HR; Chen CZ; Cohen AT; Grosso MA; Meyer G; Raskob G; Segers A; Vanassche T; Verhamme P; Wells PS; Zhang G; Weitz JI
Lancet Haematol; 2016 Sep; 3(9):e437-45. PubMed ID: 27570090
[TBL] [Abstract][Full Text] [Related]
52. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
Robertson L; Yeoh SE; Ramli A
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199
[TBL] [Abstract][Full Text] [Related]
53. Clinical outcome of patients with major bleeding after venous thromboembolism. Findings from the RIETE Registry.
Nieto JA; Camara T; Gonzalez-Higueras E; Ruiz-Gimenez N; Guijarro R; Marchena PJ; Monreal M;
Thromb Haemost; 2008 Nov; 100(5):789-96. PubMed ID: 18989522
[TBL] [Abstract][Full Text] [Related]
54. Comparison Between Non-vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous Thromboembolism.
Chen DY; Tseng CN; Hsieh MJ; Lan WC; Chuang CK; Pang ST; Chen SW; Chen TH; Chang SH; Hsieh IC; Chu PH; Wen MS; Chen JS; Chang JW; See LC; Huang WK
JAMA Netw Open; 2021 Feb; 4(2):e2036304. PubMed ID: 33533929
[TBL] [Abstract][Full Text] [Related]
55. Sex differences in patients receiving anticoagulant therapy for venous thromboembolism.
Blanco-Molina A; Enea I; Gadelha T; Tufano A; Bura-Riviere A; Di Micco P; Bounameaux H; González J; Villalta J; Monreal M;
Medicine (Baltimore); 2014 Oct; 93(17):309-317. PubMed ID: 25398066
[TBL] [Abstract][Full Text] [Related]
56. Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study.
Bikdeli B; Piazza G; Jimenez D; Muriel A; Wang Y; Khairani CD; Rosovsky RP; Mehdipoor G; O'Donoghue ML; Spagnolo P; Dreyer RP; Bertoletti L; López-Jiménez L; Núñez MJ; Blanco-Molina Á; Bates SM; Gerhard-Herman M; Goldhaber SZ; Monreal M; Krumholz HM
Thromb Res; 2022 Jun; 214():122-131. PubMed ID: 35537232
[TBL] [Abstract][Full Text] [Related]
57. Anticoagulant therapy for venous thromboembolism in patients with inflammatory bowel disease.
Lobo JL; Garcia-Fuertes JA; Trujillo-Santos J; Merah A; Blanco-Molina MÁ; Casado I; Hirmerova J; De Miguel J; Salgado E; Monreal M;
Eur J Gastroenterol Hepatol; 2018 May; 30(5):526-530. PubMed ID: 29462026
[TBL] [Abstract][Full Text] [Related]
58. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
[TBL] [Abstract][Full Text] [Related]
59. Global Anticoagulant Registry in the Field - Venous Thromboembolism (GARFIELD-VTE). Rationale and design.
Weitz JI; Haas S; Ageno W; Angchaisuksiri P; Bounameaux H; Nielsen JD; Goldhaber SZ; Goto S; Kayani G; Mantovani L; Prandoni P; Schellong S; Turpie AG; Kakkar AK
Thromb Haemost; 2016 Nov; 116(6):1172-1179. PubMed ID: 27656711
[TBL] [Abstract][Full Text] [Related]
60. Venous thromboembolism (VTE) prevention and diagnosis in COVID-19: Practice patterns and outcomes at 33 hospitals.
Parks AL; Auerbach AD; Schnipper JL; Bertram A; Jeon SY; Boyle B; Fang MC; Gadrey SM; Siddiqui ZK; Brotman DJ;
PLoS One; 2022; 17(5):e0266944. PubMed ID: 35511940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
